Click Here to Download the Ofloxacin Med Guide

Jay Shukla - RPh, MBA
President & CEO

As a registered pharmacist with an MBA in pharmaceutical management, and over 20 years of diverse experience both in Asia and the USA, Jay brings expertise from both sides of the world. He specializes in business development, corporate strategy, sourcing and international business.

Jay acquired more than 4 years of Indian pharmaceutical industry experience where he worked at different levels of supply chains: starting as a sales representative, and going up to product manager, and everything in between.

Jay has worked in the US pharmaceutical industry for more than 16 years, again starting as pharmacist behind the counter, and then moving on to sourcing manager, and policy advisor to the largest state run Medicaid program in the US.

Jay holds a B.S. in pharmacy from K.L.E.’s College of Pharmacy, Banglore, India, and an MBA in Pharmaceutical Studies from Silberman College of Business, Madison, New Jersey.

 

Robert Miller
Chief Financial Officer

Robert Miller brings a great depth of financial expertise to Nivagen.  He served as Chief Financial Officer at Sonoma Pharmaceuticals for 14 years.

Bob’s extensive experience includes CFO positions at: GAF Corporation, Penwest Co., Ameron Corp., and Bugle Boy. He also served as Treasurer of Mead Corporation, and as Vice President of investment banking at Blyth, Eastman Dillon & Co.  Bob cut his teeth as an analyst in investment banking at Merrill Lynch.

Bob graduated from Stanford University with a BA in Economics, and holds an MBA from Columbia University in Finance.  He also served in U.S. Marine Corps as a captain, where he received a Purple Heart.

 

Dr. Dasaradhi Lakkaraju,  PhD
Chief Science Officer

​Dr. Das g​ot his Ph.D from Osmania university and did​ his​ Postdoctoral fellowship in ​the ​Department of Chemistry at University of Durham in England, New Mexico State University​,​ and at ​the ​Department of Pharmacology in State University of New York, Stony ​B​rook.​ ​

Dr. Das brings a tremendous amount of knowledge that was built over 24 years of analytical chemistry experience in the pharmaceutical industry. ​He has experience in solid orals​, ​both extended release and immediate release tablets​,​ and capsule formulations including controlled substances, as well as parenteral: lyophilized products and liquids, oil based depot formulations, suspensions, peptides, steroids and oncology products, ophthalmic: liquids and suspensions. He has lead intellectual property development projects using reverse engineering techniques and circumventing patents for Paragraph-IV filings. 

He has contributed significantly to several ANDAS, NDAs and 505(b)(2)s. He has published 24 papers in peer reviewed Journals and also has patents in formulation development.

Anand Shukla, MS, MBA
Vice President, Research & Development

Anand brings more than 20 years experience in the pharmaceutical and healthcare industries. including formulation development, business development, project management, capital planning and investor relations.

Prior to joining Nivagen, Anand held various technical roles in pharmaceutical and biotechnology companies such as Andrx, Watson, Fibrogen and Sandoz. In addition to developing ANDAs, NDAs and 505(b)(2)s, Anand has extensive experience in project management, business development, strategic planning and fund raising. Mr. Shukla made significant contributions to development of many complex branded and generic products such as modified-release solid oral dosage form, lyophilized injectables and topical products.

Anand holds a Masters degree in Industrial Pharmacy from Long Island University, Brooklyn, NY and an MBA from John Sperling School of Business.

Tom Henry
Vice President, Sales Development

Tom Henry brings over 24 years of pharmaceutical sales expertise to the Nivagen team. Upon graduation from Emory University, he launched his career at Goldline Laboratories. After 7 years selling generic products for a full line re-packager, he saw the shift to manufacturers distributing under their own label. For the next 17 years he covered the Western US for ETHEX Corporation. He then consulted for both branded and generic companies before joining Nivagen Pharmaceuticals, Inc. in 2014. Tom is knowledgeable in all aspects of the business, from behind-the-scenes new product set up and sales tracking, to customer-facing product launches and contract negotiations.    

It’s no surprise that Tom Henry ended up in pharmaceutical sales – with a McKesson sales rep father, he practically grew up in the drug industry!

 

Andrea Felix
National Account Director, Sales Development

Andrea Felix brings over 25 years of pharmaceutical sales expertise to the Nivagen team. After three years of working as a Registered Nurse for UCLA Medical Center, she joined Fougera Pharmaceuticals in 1994 as a sales representative calling on independent pharmacies and hospitals.  Four years later she was promoted to National Account Executive calling on small to mid-size retailers and distributors, and in 1998 she was promoted to National Account Director calling on large retailers and wholesalers and where she spent 13 years. In 2007 she joined Perrigo Pharmaceuticals as Director – National Accounts, working there for 11 years.

Andrea is knowledgeable in all aspects of the business, from generics, branded, and OTCs, new product set up and sales tracking, to customer-facing product launches and contract negotiations. Her medical background coupled with the fact that her father worked in the wholesale industry for 40 years made pharmaceutical sales a perfect fit for Andrea.